GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Roivant Sciences Ltd (STU:87S) » Definitions » Price-to-Funds-From-Operations

Roivant Sciences (STU:87S) Price-to-Funds-From-Operations : (As of Apr. 10, 2025)


View and export this data going back to 2023. Start your Free Trial

What is Roivant Sciences Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Roivant Sciences Business Description

Industry
Traded in Other Exchanges
Address
50 Broadway, 7th Floor, London, GBR, SW1H 0BD
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.